Prestige Consumer Healthcare Inc.
NYSEPBH reports its Q4 2026 results on May 14 with an unusual cluster of executive selling pressure competing against the most aggressive short-interest build in months. The most striking signal into today's print is the insider activity. CEO Ron Lombardi and CFO Christine Sacco both sold shares on May 5 and May 7 — just days before the earnings release. Lombardi disposed of a combined…
Snapshot as of 14 May 2026
PBH reports its Q4 2026 results on May 14 with an unusual cluster of executive selling pressure competing against the most aggressive short-interest build in months. The most striking signal into today's print is the…
PBH heads into tomorrow's Q4 earnings with a sharply contradictory setup: insiders dumped shares at the top of the week, short sellers piled in at a one-month record pace, yet options traders are leaning bullish. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PBH — free to start on ORTEX.
Sign up for free →Open PBH on ORTEX